SE9201189D0 - Foerbaettringar vid organiska foereningar - Google Patents

Foerbaettringar vid organiska foereningar

Info

Publication number
SE9201189D0
SE9201189D0 SE9201189A SE9201189A SE9201189D0 SE 9201189 D0 SE9201189 D0 SE 9201189D0 SE 9201189 A SE9201189 A SE 9201189A SE 9201189 A SE9201189 A SE 9201189A SE 9201189 D0 SE9201189 D0 SE 9201189D0
Authority
SE
Sweden
Prior art keywords
societies
organic
clozapine
pharmaceutical compositions
invention concerns
Prior art date
Application number
SE9201189A
Other languages
English (en)
Swedish (sv)
Other versions
SE9201189L (sv
Inventor
Volker Fischer
Ronald Paul Mason
Original Assignee
Sandoz Sa
Us Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa, Us Commerce filed Critical Sandoz Sa
Publication of SE9201189L publication Critical patent/SE9201189L/xx
Publication of SE9201189D0 publication Critical patent/SE9201189D0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE9201189A 1990-08-20 1992-04-14 Foerbaettringar vid organiska foereningar SE9201189D0 (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56968990A 1990-08-20 1990-08-20
US71713691A 1991-06-18 1991-06-18
PCT/EP1991/001542 WO1992003138A1 (en) 1990-08-20 1991-08-14 Improvements in or relating to organic compounds

Publications (2)

Publication Number Publication Date
SE9201189L SE9201189L (sv) 1992-04-14
SE9201189D0 true SE9201189D0 (sv) 1992-04-14

Family

ID=27075116

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9201189A SE9201189D0 (sv) 1990-08-20 1992-04-14 Foerbaettringar vid organiska foereningar

Country Status (30)

Country Link
US (2) US5312819A (tr)
JP (1) JPH0813745B2 (tr)
KR (1) KR100189349B1 (tr)
AT (1) AT400522B (tr)
AU (1) AU649269B2 (tr)
BE (1) BE1006878A5 (tr)
CA (1) CA2065421A1 (tr)
CH (1) CH684162A5 (tr)
CZ (1) CZ281843B6 (tr)
DE (1) DE4191979T (tr)
DK (1) DK51292A (tr)
ES (1) ES2078838B1 (tr)
FI (1) FI913888A (tr)
FR (1) FR2665835B1 (tr)
GB (1) GB2254252B (tr)
GR (1) GR1002188B (tr)
HU (1) HUT60137A (tr)
IE (1) IE66121B1 (tr)
IL (1) IL99224A (tr)
IT (1) IT1251226B (tr)
LU (1) LU88099A1 (tr)
MX (1) MX9100742A (tr)
MY (1) MY107976A (tr)
NL (1) NL9120006A (tr)
NZ (1) NZ239464A (tr)
PT (1) PT98707B (tr)
RU (1) RU2080860C1 (tr)
SE (1) SE9201189D0 (tr)
SK (1) SK279225B6 (tr)
WO (1) WO1992003138A1 (tr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2935292A (en) * 1991-10-31 1993-06-07 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Prevention of drug-induced agranulocytosis with free radical scavengers
US5538965A (en) * 1993-12-23 1996-07-23 Allelix Biopharmaceuticals Inc. Dopamine receptor ligands
CA2735293A1 (en) * 1995-01-17 1996-07-18 Menuco Corp. Nadh and nadph therapeutic agents for dermal administration
JP3889481B2 (ja) * 1996-08-16 2007-03-07 株式会社カネカ 医薬組成物
ES2258825T3 (es) * 1997-10-27 2006-09-01 Cortex Pharmaceuticals, Inc. Tratamiento de la esquizofrenia con ampakinas y neurolepticos.
US8753675B1 (en) * 2000-01-20 2014-06-17 Raj K. Chopra Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications
JP2003026567A (ja) * 2001-05-10 2003-01-29 Kanegafuchi Chem Ind Co Ltd 補酵素ｑを有効成分とする粘膜投与用組成物
NZ527142A (en) * 2003-07-23 2006-03-31 Douglas Pharmaceuticals Ltd A stable suspension formulation
WO2010011232A1 (en) * 2008-07-24 2010-01-28 Handa Pharmaceuticals, Llc Stabilized atypical antipsychotic formulation
RU2610169C2 (ru) * 2014-09-11 2017-02-08 Общество С Ограниченной Ответственностью "Валентек" ПРОИЗВОДНЫЕ 7-ФТОРО-8-ХЛОРО-5Н-ДИБЕНЗО[b, е][1, 4]ДИАЗЕПИНА И ИХ ПРИМЕНЕНИЕ

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI50242C (fi) * 1969-07-18 1976-01-12 Thomae Gmbh Dr K Menetelmä valmistaa farmakologisesti aktiivisia uusia diallyyliaminoal kanoyylidibenso- tai pyridobenso-diatsepiineja ja niiden happoadditios uoloja.
US3983234A (en) * 1974-07-04 1976-09-28 Sandoz Ltd. Treatment of dyskinesias
US4028467A (en) * 1975-01-07 1977-06-07 Berger Frank M Analgesic compositions comprising levo-propoxyphene and benzo diazepine and process
GB1498857A (en) * 1975-07-03 1978-01-25 Leo Ab Antidepressant composition
EP0026469B1 (en) * 1979-10-01 1984-11-28 Sandoz Ag Dibenzazepine derivatives, their production and pharmaceutical compositions containing them
US4761411A (en) * 1983-05-18 1988-08-02 Hoechst-Roussel Pharmaceuticals Inc. Dihydrobenzopyrrolobenzodiazepines useful for treating pyschoses
DE3542309A1 (de) * 1985-11-29 1987-06-04 Cardona Federico Dr Medizinisches antioxidativum
US4973586A (en) * 1986-01-16 1990-11-27 Schering Corporation Fused benzazepines, compositions of, and medical use thereof
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
CA1327008C (en) * 1988-01-15 1994-02-15 Walter Merz Anti-psychotic imidazobenzodiazepine
US4996199A (en) * 1988-04-08 1991-02-26 Whitby Research, Inc. Penetration enhancers for transdermal delivery of systemic agents
JP2903318B2 (ja) * 1989-04-04 1999-06-07 日研フード株式会社 抗酸化的ストレス物

Also Published As

Publication number Publication date
DK51292D0 (da) 1992-04-15
IE66121B1 (en) 1995-12-13
KR100189349B1 (en) 1999-06-01
IL99224A0 (en) 1992-07-15
CS55092A3 (en) 1992-08-12
GB9206101D0 (en) 1992-06-24
SE9201189L (sv) 1992-04-14
AU8396391A (en) 1992-03-17
FI913888A0 (fi) 1991-08-16
IE912934A1 (en) 1992-02-26
AT400522B (de) 1996-01-25
MX9100742A (es) 1992-04-01
GB2254252A (en) 1992-10-07
HU9201090D0 (en) 1992-06-29
GR1002188B (en) 1996-03-13
NZ239464A (en) 1993-10-26
ATA900491A (de) 1995-06-15
GB2254252B (en) 1994-06-01
RU2080860C1 (ru) 1997-06-10
NL9120006A (nl) 1992-08-03
ES2078838B1 (es) 1997-02-01
BE1006878A5 (fr) 1995-01-17
DK51292A (da) 1992-04-15
US5563134A (en) 1996-10-08
FR2665835B1 (fr) 1995-06-23
AU649269B2 (en) 1994-05-19
LU88099A1 (de) 1992-11-16
PT98707A (pt) 1992-07-31
ITMI912261A0 (it) 1991-08-20
HUT60137A (en) 1992-08-28
DE4191979T (tr) 1992-10-08
KR920702225A (ko) 1992-09-03
JPH0813745B2 (ja) 1996-02-14
GR910100361A (el) 1992-08-31
FI913888A (fi) 1992-02-21
US5312819A (en) 1994-05-17
CA2065421A1 (en) 1992-02-21
FR2665835A1 (fr) 1992-02-21
CZ281843B6 (cs) 1997-02-12
IL99224A (en) 1996-01-31
ES2078838A1 (es) 1995-12-16
ITMI912261A1 (it) 1993-02-20
SK279225B6 (sk) 1998-08-05
WO1992003138A1 (en) 1992-03-05
IT1251226B (it) 1995-05-05
PT98707B (pt) 1999-01-29
MY107976A (en) 1996-07-15
CH684162A5 (de) 1994-07-29
JPH05503296A (ja) 1993-06-03

Similar Documents

Publication Publication Date Title
ATE134477T1 (de) Biozide zusammensetzungen
BR9106438A (pt) Composicoes terapeuticas sinergisticas e processos
BR9101035A (pt) Composicao e composto alvejante
PT589843E (pt) Composicoes farmaceuticas contendo ciclosporinas
DE69213702T2 (de) Feldeffekttransistor
DE69327836T2 (de) Härtbare und gehärtete Organosilikonzusammensetzungen
DE69223706D1 (de) Feldeffekttransistor
DE69325673D1 (de) Feldeffekttransistor
DE69233115D1 (de) Weitere therapeutische Verwendungen von L-Methionine und Zusammensetzungen
DE69312499D1 (de) Kautschukzusammensetzungen enthaltend epoxidierten naturkautschuk und naturkautschuk
DE69202164D1 (de) Stabilisierung von Thiolenzusammensetzungen.
ITRM910952A0 (it) Composizioni farmaceutiche contenenti gonadotropine
MX9201710A (es) Carbamatos de rapamicina y composicion farmaceutica que los contiene.
FI941968A0 (fi) Rengas- ja hihnakoostumuksia
SE9201189L (sv) Foerbaettringar vid organiska foereningar
DE69227976D1 (de) Amphotere Zusammensetzungen
DE69432985D1 (de) Synergistische anthelmintische zusammensetzungen gegen fasciola hepatica und andere fascola spezien
MX9200146A (es) Composiciones farmaceuticas deglutibles
BR9200875A (pt) Produto de adicao e composicao de oxigenio
IT1290797B1 (it) Composizioni farmaceutiche stabilizzate
IT1243441B (it) Composizioni di polifenilenossido o di miscele di polifenilenossido ststabilizzate con beta-dichetoni
DE69208297T2 (de) Feldeffekttransistor
DE69209115D1 (de) Sauerstoffradikalfänger
BR9203043A (pt) Composicao alvejante
ATE139519T1 (de) Stabilisiertes 141b

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9201189-9

Format of ref document f/p: F